3D printing in healthcare market seen reaching $5.99 billion by 2030

The Business Research Company says the 3D printing in healthcare market is on track to rise from $2.95 billion in 2026 to $5.99 billion by 2030, driven by personalized medicine, bioprinting and broader use of printed medical devices. North America led in 2025, while Asia Pacific is projected to grow fastest.

Why it matters: - 3D printing is moving deeper into healthcare manufacturing and treatment planning. - The shift supports patient-specific devices, surgical models and customized implants. - The market’s growth signals rising demand for personalized care and point-of-care production.

What happened: - The Business Research Company published a 2026 market report on 3D printing in healthcare. - The report estimates the market will grow from $2.47 billion in 2025 to $2.95 billion in 2026. - The report forecasts the market will reach $5.99 billion by 2030. - The report was released July 23, 2026.

The details: - The 2026-to-2030 forecast implies a 19.4% CAGR. - Recent market growth was driven by additive manufacturing advances, early use of 3D-printed surgical guides, academic research, wider use of anatomical models and more printable biomaterials. - Future growth is expected from bioprinting research funding, demand for personalized healthcare products, regenerative medicine use cases, point-of-care manufacturing and more regulatory approvals for printed medical devices. - The report highlights growing use of patient-specific medical devices, bioprinting technologies, customized surgical models, 3D-printed implants and prosthetics, and tighter links between digital design and manufacturing. - 3D printing in healthcare uses digital designs to build objects layer by layer for medical purposes. - The technology is used for patient-specific medical devices, anatomical models for education and surgery planning, and customized surgical instruments. - Chronic disease growth is a major demand driver. - The report cites diabetes, hypertension and arthritis as key chronic conditions pushing adoption. - The report links this demand to lifestyle factors including sedentary behavior, processed foods, tobacco and alcohol use. - Data from the UK National Health Service showed 3,615,330 people registered with general practitioners were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, up 18% from 3,065,825 in 2022. - The report says that rise reflects growing demand for customized implants and devices. - North America held the largest market share in 2025. - Asia Pacific is expected to grow fastest during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report edition adds market attractiveness scoring, total addressable market analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics and updated graphics and tables. - The company made free sample and full report links available: Download a free sample and View the full report.

Between the lines: - The report points to a market moving from niche medical prototyping toward broader clinical and manufacturing use. - Faster growth in Asia Pacific suggests healthcare investment and adoption may be spreading beyond established markets. - The combination of chronic disease pressure and personalization trends gives 3D printing a clear commercial and clinical use case.

What's next: - The market is expected to keep expanding as bioprinting research, regulatory approvals and point-of-care manufacturing advance. - Printed implants, prosthetics and patient-specific devices are likely to become more common in medical workflows. - The report frames digital-to-manufacturing integration as a key trend to watch through 2030.